Target intelligence / Profile preview

Small ribosomal subunit protein mS38, mitochondrial (AURKAIP1)

Target
AURKAIP1
Molecular classification
Other (mitochondrial ribosomal protein)
01

Overview

Small ribosomal subunit protein mS38, mitochondrial (AURKAIP1) is a mitochondrial matrix protein that functions as a constituent of the small subunit of the mitochondrial ribosome, playing an indispensable role in mitochondrial protein synthesis. It also acts in the nucleoplasm and is involved in the negative regulation of Aurora kinase A (Aurora-A), a mitotic kinase and proto-oncogene. AURKAIP1 binds to Aurora-A and promotes its proteasome-dependent, ubiquitin-independent degradation, an activity critical for normal cell cycle progression and suppression of oncogenic transformation. Depletion of AURKAIP1 leads to defective mitochondrial protein synthesis, affecting cellular energy homeostasis, and altering cell cycle control[1][2][3]. Key points: - AURKAIP1 is a dual-function protein: a core structural mitochondrial ribosomal protein (mS38) and a regulator of mitotic kinase Aurora-A[1][3]. - Its canonical role is not as a classical drug target (receptor, enzyme, transporter) but as a ribosomal protein and regulator of cell cycle machinery[1][3]. - Manipulation of AURKAIP1 levels may influence mitochondrial translation and tumorigenic processes by altering Aurora-A degradation, implicating a disease linkage to cancer biology, though there are no known direct drugs or clinical biomarkers acting via AURKAIP1 as a primary molecular target[1][2][3]. - Common aliases include AURKAIP1, MRP-S38, AKIP, AIP, MRPS38, mS38[1][5].

Other names
Aurora kinase A interacting protein 1MRP-S38AKIPAIPMRPS38FLJ20608mS3828S ribosomal protein S38, mitochondrialAurora-A kinase interacting protein 1
02

Biological functions

Positive regulation of proteolysisMitochondrial translationRegulation of Aurora-A kinase stabilityCell cycle regulation
03

Disease associations

Cancer (implicated as a regulator of Aurora kinase A, an oncogene)

Beyond the preview

Go deeper on Small ribosomal subunit protein mS38, mitochondrial (AURKAIP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small ribosomal subunit protein mS38, mitochondrial (AURKAIP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call